CCNB1

UniProt ID: P14635
Organism: Homo sapiens
Review Status: COMPLETE
πŸ“ Provide Detailed Feedback

Gene Description

CCNB1 encodes cyclin B1, the principal B-type mitotic cyclin (cyclin AB subfamily) and the regulatory subunit of the cyclin-dependent kinase CDK1 (CDC2). Cyclin B1 is not itself an enzyme; it binds CDK1 to form the cyclin B1-CDK1 holoenzyme, historically called M-phase/maturation-promoting factor (MPF), and induces the active kinase conformation while conferring substrate specificity and subcellular targeting on CDK1. Cyclin B1 accumulates through G2 and, once its associated CDK1 is activated (following CDC25-mediated removal of inhibitory Thr14/Tyr15 phosphorylation and reversal of WEE1/PKMYT1 inhibition), the complex drives the G2/M transition and mitotic entry. Cyclin B1 has no single static location: it is predominantly cytoplasmic during interphase, shuttles through the nucleus, and accumulates in the nucleus at prophase after phosphorylation of its cytoplasmic-retention/nuclear-export region; active cyclin B1-CDK1 first appears on centrosomes, and the protein also localizes to spindle microtubules, condensed chromosomes and unattached kinetochores. Through localized CDK1 phosphorylation of substrates (nuclear lamins, condensins, MPS1, separase and many others) it promotes centrosome separation, chromosome condensation, nuclear-envelope breakdown, spindle assembly, correct kinetochore-microtubule attachment and spindle-assembly-checkpoint control. At the metaphase-to-anaphase transition cyclin B1 is polyubiquitinated by the APC/C-CDC20 complex and destroyed by the proteasome; loss of cyclin B1 inactivates CDK1 and drives mitotic exit. A minor fraction of cyclin B1-CDK1 also localizes to the mitochondrial matrix, where it phosphorylates respiratory complex I subunits to support the energetic demands of the G2/M transition.

Existing Annotations Review

GO Term Evidence Action Reason
GO:0000082 G1/S transition of mitotic cell cycle
IBA
GO_REF:0000033
MARK AS OVER ANNOTATED
Summary: IBA propagation of G1/S transition from the ancestral cyclin node. Cyclin B1 is the mitotic B-type cyclin; G1/S commitment is driven by the G1/S cyclins (E/A), not cyclin B1.
Reason: The PANTHER cyclin node PTN000019791 groups G1/S cyclins (cyclin E/A/D) with mitotic cyclins (cyclin A/B); the G1/S-transition function is a cyclin E/A activity that has functionally diverged from the B-type cyclins. Cyclin B1 acts at the G2/M transition, not G1/S, so this term over-reaches when propagated to CCNB1.
Propagation Review
Root cause: PROPAGATION BAD
Failure modes: FUNCTIONAL DIVERGENCE
Sources checked:
PANTHER:PTN000019791 SUPPORTS SOURCE BUT NOT TARGET
Ancestral cyclin node spanning G1/S (cyclin E/A/D) and mitotic (cyclin A/B) cyclins; G1/S transition is inherited by the G1/S cyclins, not by the mitotic B-type cyclin CCNB1.
GO:0000086 G2/M transition of mitotic cell cycle
NAS
PMID:17495531
Cyclin B and cyclin A confer different substrate recognition...
ACCEPT
Summary: Core biological process for cyclin B1. Cyclin B1-CDK1 is the master driver of the G2/M transition.
Reason: Cyclin B1 accumulates through G2 and its complex with CDK1 initiates mitosis; this is the defining function of the gene. Supported directly by structural/biochemical work on cyclin B and by the broader literature.
Supporting Evidence:
PMID:17495531
cyclin B confers M phase-like properties on CDK2
GO:0000922 spindle pole
IDA
PMID:18195732
Cyclin B1 is localized to unattached kinetochores and contri...
ACCEPT
Summary: Cyclin B1 is displaced from kinetochores to spindle poles upon microtubule attachment (Chen et al. 2008).
Reason: Direct localization evidence: cyclin B1 relocates to spindle poles as kinetochore-microtubule attachment completes.
Supporting Evidence:
PMID:18195732
Cyclin B1 is displaced from individual kinetochores to the spindle poles by microtubule attachment to the kinetochores
GO:0000940 outer kinetochore
IDA
PMID:18195732
Cyclin B1 is localized to unattached kinetochores and contri...
ACCEPT
Summary: Cyclin B1 concentrates on the outer plate of the kinetochore during prometaphase (Chen et al. 2008).
Reason: Direct experimental localization to the outer kinetochore, where cyclin B1-CDK1 acts on local substrates to promote correct microtubule attachment.
Supporting Evidence:
PMID:18195732
cyclin B1 is concentrated on the outer plate of the kinetochore during prometaphase
GO:0001556 oocyte maturation
IEA
GO_REF:0000107
KEEP AS NON CORE
Summary: Cyclin B1-CDK1 (MPF) drives oocyte meiotic maturation, a conserved role. Electronically transferred from the rat ortholog.
Reason: A genuine conserved cyclin B1 function (MPF in meiotic maturation) but developmental/context-specific and not the core mitotic function; supported here only by automated ortholog transfer, so retained as non-core.
GO:0005113 patched binding
IPI
PMID:11331587
Patched1 interacts with cyclin B1 to regulate cell cycle pro...
KEEP AS NON CORE
Summary: Cyclin B1 binds patched1 (PTCH1); PTCH1 controls cyclin B1 subcellular localization (Barnes et al. 2001).
Reason: A specific, informative molecular-function annotation (binding to a patched receptor) supported by two-hybrid and endogenous co-IP. It is a real but peripheral regulatory interaction, not the core CDK-activation function, so retained as non-core.
Supporting Evidence:
PMID:11331587
we identified a novel interaction between cyclin B1 and patched1 (ptc1)
GO:0005515 protein binding
IPI
PMID:10373560
Overproduction of human Myt1 kinase induces a G2 cell cycle ...
REMOVE
Summary: Generic "protein binding" (interactor: PKMYT1 (Myt1)). The interaction is not disputed, but GO:0005515 conveys no molecular function.
Reason: Per project curation policy, uninformative generic protein_binding is removed. Cyclin B1's informative molecular activity (CDK1 activation and substrate targeting) is captured by GO:0061575 / GO:0016538, and specific interactions such as protein kinase binding (GO:0019901) and patched binding (GO:0005113) are retained separately. Removal does not dispute the reported PKMYT1 (Myt1) interaction.
GO:0005515 protein binding
IPI
PMID:12612082
A novel RING finger protein, human enhancer of invasion 10, ...
REMOVE
Summary: Generic "protein binding" (interactor: CDK1). The interaction is not disputed, but GO:0005515 conveys no molecular function.
Reason: Per project curation policy, uninformative generic protein_binding is removed. Cyclin B1's informative molecular activity (CDK1 activation and substrate targeting) is captured by GO:0061575 / GO:0016538, and specific interactions such as protein kinase binding (GO:0019901) and patched binding (GO:0005113) are retained separately. Removal does not dispute the reported CDK1 interaction.
GO:0005515 protein binding
IPI
PMID:12612082
A novel RING finger protein, human enhancer of invasion 10, ...
REMOVE
Summary: Generic "protein binding" (interactor: CCNB1IP1/HEI10). The interaction is not disputed, but GO:0005515 conveys no molecular function.
Reason: Per project curation policy, uninformative generic protein_binding is removed. Cyclin B1's informative molecular activity (CDK1 activation and substrate targeting) is captured by GO:0061575 / GO:0016538, and specific interactions such as protein kinase binding (GO:0019901) and patched binding (GO:0005113) are retained separately. Removal does not dispute the reported CCNB1IP1/HEI10 interaction.
Supporting Evidence:
PMID:12612082
the mitotic cyclin B1 and an E2 ubiquitin-conjugating enzyme were isolated as HEI10-interacting proteins
GO:0005515 protein binding
IPI
PMID:15790566
Cdk5 activator-binding protein C53 regulates apoptosis induc...
REMOVE
Summary: Generic "protein binding" (interactor: CDK5RAP3 (C53)). The interaction is not disputed, but GO:0005515 conveys no molecular function.
Reason: Per project curation policy, uninformative generic protein_binding is removed. Cyclin B1's informative molecular activity (CDK1 activation and substrate targeting) is captured by GO:0061575 / GO:0016538, and specific interactions such as protein kinase binding (GO:0019901) and patched binding (GO:0005113) are retained separately. Removal does not dispute the reported CDK5RAP3 (C53) interaction.
GO:0005515 protein binding
IPI
PMID:17283331
Death-effector domain-containing protein DEDD is an inhibito...
REMOVE
Summary: Generic "protein binding" (interactor: DEDD). The interaction is not disputed, but GO:0005515 conveys no molecular function.
Reason: Per project curation policy, uninformative generic protein_binding is removed. Cyclin B1's informative molecular activity (CDK1 activation and substrate targeting) is captured by GO:0061575 / GO:0016538, and specific interactions such as protein kinase binding (GO:0019901) and patched binding (GO:0005113) are retained separately. Removal does not dispute the reported DEDD interaction.
Supporting Evidence:
PMID:17283331
DEDD associates with mitotic Cdk1/cyclin B1 complexes via direct binding to cyclin B1 and reduces their function
GO:0005515 protein binding
IPI
PMID:17283331
Death-effector domain-containing protein DEDD is an inhibito...
REMOVE
Summary: Generic "protein binding" (interactor: CDK1). The interaction is not disputed, but GO:0005515 conveys no molecular function.
Reason: Per project curation policy, uninformative generic protein_binding is removed. Cyclin B1's informative molecular activity (CDK1 activation and substrate targeting) is captured by GO:0061575 / GO:0016538, and specific interactions such as protein kinase binding (GO:0019901) and patched binding (GO:0005113) are retained separately. Removal does not dispute the reported CDK1 interaction.
GO:0005515 protein binding
IPI
PMID:18337751
cdc2-cyclin B regulates eEF2 kinase activity in a cell cycle...
REMOVE
Summary: Generic "protein binding" (interactor: CDK1). The interaction is not disputed, but GO:0005515 conveys no molecular function.
Reason: Per project curation policy, uninformative generic protein_binding is removed. Cyclin B1's informative molecular activity (CDK1 activation and substrate targeting) is captured by GO:0061575 / GO:0016538, and specific interactions such as protein kinase binding (GO:0019901) and patched binding (GO:0005113) are retained separately. Removal does not dispute the reported CDK1 interaction.
Supporting Evidence:
PMID:18337751
cdc2-cyclin B complexes phosphorylate eEF2K at Ser359
GO:0005515 protein binding
IPI
PMID:18408765
CDK1 promotes cell proliferation and survival via phosphoryl...
REMOVE
Summary: Generic "protein binding" (interactor: CDK1). The interaction is not disputed, but GO:0005515 conveys no molecular function.
Reason: Per project curation policy, uninformative generic protein_binding is removed. Cyclin B1's informative molecular activity (CDK1 activation and substrate targeting) is captured by GO:0061575 / GO:0016538, and specific interactions such as protein kinase binding (GO:0019901) and patched binding (GO:0005113) are retained separately. Removal does not dispute the reported CDK1 interaction.
GO:0005515 protein binding
IPI
PMID:19502428
Kinase activity-independent regulation of cyclin pathway by ...
REMOVE
Summary: Generic "protein binding" (interactor: PTCH1). The interaction is not disputed, but GO:0005515 conveys no molecular function.
Reason: Per project curation policy, uninformative generic protein_binding is removed. Cyclin B1's informative molecular activity (CDK1 activation and substrate targeting) is captured by GO:0061575 / GO:0016538, and specific interactions such as protein kinase binding (GO:0019901) and patched binding (GO:0005113) are retained separately. Removal does not dispute the reported PTCH1 interaction.
GO:0005515 protein binding
IPI
PMID:19879842
Regulation of MBK-2/DYRK by CDK-1 and the pseudophosphatases...
REMOVE
Summary: Generic "protein binding" (interactor: CDK1). The interaction is not disputed, but GO:0005515 conveys no molecular function.
Reason: Per project curation policy, uninformative generic protein_binding is removed. Cyclin B1's informative molecular activity (CDK1 activation and substrate targeting) is captured by GO:0061575 / GO:0016538, and specific interactions such as protein kinase binding (GO:0019901) and patched binding (GO:0005113) are retained separately. Removal does not dispute the reported CDK1 interaction.
GO:0005515 protein binding
IPI
PMID:20965177
Hip2 interacts with cyclin B1 and promotes its degradation t...
REMOVE
Summary: Generic "protein binding" (interactor: UBE2K (Hip2)). The interaction is not disputed, but GO:0005515 conveys no molecular function.
Reason: Per project curation policy, uninformative generic protein_binding is removed. Cyclin B1's informative molecular activity (CDK1 activation and substrate targeting) is captured by GO:0061575 / GO:0016538, and specific interactions such as protein kinase binding (GO:0019901) and patched binding (GO:0005113) are retained separately. Removal does not dispute the reported UBE2K (Hip2) interaction.
Supporting Evidence:
PMID:20965177
Hip2 was found to interact with cyclin B1 to promote its degradation through the ubiquitin proteasome pathway
GO:0005515 protein binding
IPI
PMID:21540187
Inhibitor of cyclin-dependent kinase (CDK) interacting with ...
REMOVE
Summary: Generic "protein binding" (interactor: INCA1). The interaction is not disputed, but GO:0005515 conveys no molecular function.
Reason: Per project curation policy, uninformative generic protein_binding is removed. Cyclin B1's informative molecular activity (CDK1 activation and substrate targeting) is captured by GO:0061575 / GO:0016538, and specific interactions such as protein kinase binding (GO:0019901) and patched binding (GO:0005113) are retained separately. Removal does not dispute the reported INCA1 interaction.
GO:0005515 protein binding
IPI
PMID:21952639
NIRF constitutes a nodal point in the cell cycle network and...
REMOVE
Summary: Generic "protein binding" (interactor: UHRF2 (NIRF)). The interaction is not disputed, but GO:0005515 conveys no molecular function.
Reason: Per project curation policy, uninformative generic protein_binding is removed. Cyclin B1's informative molecular activity (CDK1 activation and substrate targeting) is captured by GO:0061575 / GO:0016538, and specific interactions such as protein kinase binding (GO:0019901) and patched binding (GO:0005113) are retained separately. Removal does not dispute the reported UHRF2 (NIRF) interaction.
GO:0005515 protein binding
IPI
PMID:23397142
Analysis of protein-protein interactions in cross-talk pathw...
REMOVE
Summary: Generic "protein binding" (interactor: PKMYT1). The interaction is not disputed, but GO:0005515 conveys no molecular function.
Reason: Per project curation policy, uninformative generic protein_binding is removed. Cyclin B1's informative molecular activity (CDK1 activation and substrate targeting) is captured by GO:0061575 / GO:0016538, and specific interactions such as protein kinase binding (GO:0019901) and patched binding (GO:0005113) are retained separately. Removal does not dispute the reported PKMYT1 interaction.
GO:0005515 protein binding
IPI
PMID:23455922
Interlaboratory reproducibility of large-scale human protein...
REMOVE
Summary: Generic "protein binding" (interactor: CDK5). The interaction is not disputed, but GO:0005515 conveys no molecular function.
Reason: Per project curation policy, uninformative generic protein_binding is removed. Cyclin B1's informative molecular activity (CDK1 activation and substrate targeting) is captured by GO:0061575 / GO:0016538, and specific interactions such as protein kinase binding (GO:0019901) and patched binding (GO:0005113) are retained separately. Removal does not dispute the reported CDK5 interaction.
GO:0005515 protein binding
IPI
PMID:23543736
Ubiquitin C-terminal hydrolase L1 (UCH-L1) acts as a novel p...
REMOVE
Summary: Generic "protein binding" (interactor: CDK1). The interaction is not disputed, but GO:0005515 conveys no molecular function.
Reason: Per project curation policy, uninformative generic protein_binding is removed. Cyclin B1's informative molecular activity (CDK1 activation and substrate targeting) is captured by GO:0061575 / GO:0016538, and specific interactions such as protein kinase binding (GO:0019901) and patched binding (GO:0005113) are retained separately. Removal does not dispute the reported CDK1 interaction.
Supporting Evidence:
PMID:23543736
UCH-L1 physically interacts with CDK1, CDK4, and CDK5, enhancing their kinase activity
GO:0005515 protein binding
IPI
PMID:23602568
The protein interaction landscape of the human CMGC kinase g...
REMOVE
Summary: Generic "protein binding" (interactor: CDK1). The interaction is not disputed, but GO:0005515 conveys no molecular function.
Reason: Per project curation policy, uninformative generic protein_binding is removed. Cyclin B1's informative molecular activity (CDK1 activation and substrate targeting) is captured by GO:0061575 / GO:0016538, and specific interactions such as protein kinase binding (GO:0019901) and patched binding (GO:0005113) are retained separately. Removal does not dispute the reported CDK1 interaction.
GO:0005515 protein binding
IPI
PMID:23602568
The protein interaction landscape of the human CMGC kinase g...
REMOVE
Summary: Generic "protein binding" (interactor: CDK5). The interaction is not disputed, but GO:0005515 conveys no molecular function.
Reason: Per project curation policy, uninformative generic protein_binding is removed. Cyclin B1's informative molecular activity (CDK1 activation and substrate targeting) is captured by GO:0061575 / GO:0016538, and specific interactions such as protein kinase binding (GO:0019901) and patched binding (GO:0005113) are retained separately. Removal does not dispute the reported CDK5 interaction.
GO:0005515 protein binding
IPI
PMID:23799914
Sulforaphane induced cell cycle arrest in the G2/M phase via...
REMOVE
Summary: Generic "protein binding" (interactor: CDK1). The interaction is not disputed, but GO:0005515 conveys no molecular function.
Reason: Per project curation policy, uninformative generic protein_binding is removed. Cyclin B1's informative molecular activity (CDK1 activation and substrate targeting) is captured by GO:0061575 / GO:0016538, and specific interactions such as protein kinase binding (GO:0019901) and patched binding (GO:0005113) are retained separately. Removal does not dispute the reported CDK1 interaction.
GO:0005515 protein binding
IPI
PMID:24358021
Polycomb protein SCML2 regulates the cell cycle by binding a...
REMOVE
Summary: Generic "protein binding" (interactor: CDK1). The interaction is not disputed, but GO:0005515 conveys no molecular function.
Reason: Per project curation policy, uninformative generic protein_binding is removed. Cyclin B1's informative molecular activity (CDK1 activation and substrate targeting) is captured by GO:0061575 / GO:0016538, and specific interactions such as protein kinase binding (GO:0019901) and patched binding (GO:0005113) are retained separately. Removal does not dispute the reported CDK1 interaction.
GO:0005515 protein binding
IPI
PMID:25852190
Integrative analysis of kinase networks in TRAIL-induced apo...
REMOVE
Summary: Generic "protein binding" (interactor: CDK1). The interaction is not disputed, but GO:0005515 conveys no molecular function.
Reason: Per project curation policy, uninformative generic protein_binding is removed. Cyclin B1's informative molecular activity (CDK1 activation and substrate targeting) is captured by GO:0061575 / GO:0016538, and specific interactions such as protein kinase binding (GO:0019901) and patched binding (GO:0005113) are retained separately. Removal does not dispute the reported CDK1 interaction.
GO:0005515 protein binding
IPI
PMID:25852190
Integrative analysis of kinase networks in TRAIL-induced apo...
REMOVE
Summary: Generic "protein binding" (interactor: CDK5). The interaction is not disputed, but GO:0005515 conveys no molecular function.
Reason: Per project curation policy, uninformative generic protein_binding is removed. Cyclin B1's informative molecular activity (CDK1 activation and substrate targeting) is captured by GO:0061575 / GO:0016538, and specific interactions such as protein kinase binding (GO:0019901) and patched binding (GO:0005113) are retained separately. Removal does not dispute the reported CDK5 interaction.
GO:0005515 protein binding
IPI
PMID:26496610
A human interactome in three quantitative dimensions organiz...
REMOVE
Summary: Generic "protein binding" (interactor: CDK1). The interaction is not disputed, but GO:0005515 conveys no molecular function.
Reason: Per project curation policy, uninformative generic protein_binding is removed. Cyclin B1's informative molecular activity (CDK1 activation and substrate targeting) is captured by GO:0061575 / GO:0016538, and specific interactions such as protein kinase binding (GO:0019901) and patched binding (GO:0005113) are retained separately. Removal does not dispute the reported CDK1 interaction.
GO:0005515 protein binding
IPI
PMID:26496610
A human interactome in three quantitative dimensions organiz...
REMOVE
Summary: Generic "protein binding" (interactor: CDKN1B (p27)). The interaction is not disputed, but GO:0005515 conveys no molecular function.
Reason: Per project curation policy, uninformative generic protein_binding is removed. Cyclin B1's informative molecular activity (CDK1 activation and substrate targeting) is captured by GO:0061575 / GO:0016538, and specific interactions such as protein kinase binding (GO:0019901) and patched binding (GO:0005113) are retained separately. Removal does not dispute the reported CDKN1B (p27) interaction.
GO:0005515 protein binding
IPI
PMID:26496610
A human interactome in three quantitative dimensions organiz...
REMOVE
Summary: Generic "protein binding" (interactor: PKMYT1). The interaction is not disputed, but GO:0005515 conveys no molecular function.
Reason: Per project curation policy, uninformative generic protein_binding is removed. Cyclin B1's informative molecular activity (CDK1 activation and substrate targeting) is captured by GO:0061575 / GO:0016538, and specific interactions such as protein kinase binding (GO:0019901) and patched binding (GO:0005113) are retained separately. Removal does not dispute the reported PKMYT1 interaction.
GO:0005515 protein binding
IPI
PMID:27626412
Sulforaphane, a Dietary Isothiocyanate, Induces Gβ‚‚/M Arrest ...
REMOVE
Summary: Generic "protein binding" (interactor: CDK1). The interaction is not disputed, but GO:0005515 conveys no molecular function.
Reason: Per project curation policy, uninformative generic protein_binding is removed. Cyclin B1's informative molecular activity (CDK1 activation and substrate targeting) is captured by GO:0061575 / GO:0016538, and specific interactions such as protein kinase binding (GO:0019901) and patched binding (GO:0005113) are retained separately. Removal does not dispute the reported CDK1 interaction.
GO:0005515 protein binding
IPI
PMID:28514442
Architecture of the human interactome defines protein commun...
REMOVE
Summary: Generic "protein binding" (interactor: CDK1). The interaction is not disputed, but GO:0005515 conveys no molecular function.
Reason: Per project curation policy, uninformative generic protein_binding is removed. Cyclin B1's informative molecular activity (CDK1 activation and substrate targeting) is captured by GO:0061575 / GO:0016538, and specific interactions such as protein kinase binding (GO:0019901) and patched binding (GO:0005113) are retained separately. Removal does not dispute the reported CDK1 interaction.
GO:0005515 protein binding
IPI
PMID:28514442
Architecture of the human interactome defines protein commun...
REMOVE
Summary: Generic "protein binding" (interactor: CDK5). The interaction is not disputed, but GO:0005515 conveys no molecular function.
Reason: Per project curation policy, uninformative generic protein_binding is removed. Cyclin B1's informative molecular activity (CDK1 activation and substrate targeting) is captured by GO:0061575 / GO:0016538, and specific interactions such as protein kinase binding (GO:0019901) and patched binding (GO:0005113) are retained separately. Removal does not dispute the reported CDK5 interaction.
GO:0005515 protein binding
IPI
PMID:32707033
Kinase Interaction Network Expands Functional and Disease Ro...
REMOVE
Summary: Generic "protein binding" (interactor: CDK1). The interaction is not disputed, but GO:0005515 conveys no molecular function.
Reason: Per project curation policy, uninformative generic protein_binding is removed. Cyclin B1's informative molecular activity (CDK1 activation and substrate targeting) is captured by GO:0061575 / GO:0016538, and specific interactions such as protein kinase binding (GO:0019901) and patched binding (GO:0005113) are retained separately. Removal does not dispute the reported CDK1 interaction.
GO:0005515 protein binding
IPI
PMID:32707033
Kinase Interaction Network Expands Functional and Disease Ro...
REMOVE
Summary: Generic "protein binding" (interactor: CDK5). The interaction is not disputed, but GO:0005515 conveys no molecular function.
Reason: Per project curation policy, uninformative generic protein_binding is removed. Cyclin B1's informative molecular activity (CDK1 activation and substrate targeting) is captured by GO:0061575 / GO:0016538, and specific interactions such as protein kinase binding (GO:0019901) and patched binding (GO:0005113) are retained separately. Removal does not dispute the reported CDK5 interaction.
GO:0005515 protein binding
IPI
PMID:32707033
Kinase Interaction Network Expands Functional and Disease Ro...
REMOVE
Summary: Generic "protein binding" (interactor: PKMYT1). The interaction is not disputed, but GO:0005515 conveys no molecular function.
Reason: Per project curation policy, uninformative generic protein_binding is removed. Cyclin B1's informative molecular activity (CDK1 activation and substrate targeting) is captured by GO:0061575 / GO:0016538, and specific interactions such as protein kinase binding (GO:0019901) and patched binding (GO:0005113) are retained separately. Removal does not dispute the reported PKMYT1 interaction.
GO:0005515 protein binding
IPI
PMID:33037310
The sequence at Spike S1/S2 site enables cleavage by furin a...
REMOVE
Summary: Generic "protein binding" (interactor: CDK1). The interaction is not disputed, but GO:0005515 conveys no molecular function.
Reason: Per project curation policy, uninformative generic protein_binding is removed. Cyclin B1's informative molecular activity (CDK1 activation and substrate targeting) is captured by GO:0061575 / GO:0016538, and specific interactions such as protein kinase binding (GO:0019901) and patched binding (GO:0005113) are retained separately. Removal does not dispute the reported CDK1 interaction.
GO:0005515 protein binding
IPI
PMID:33961781
Dual proteome-scale networks reveal cell-specific remodeling...
REMOVE
Summary: Generic "protein binding" (interactor: CDK1). The interaction is not disputed, but GO:0005515 conveys no molecular function.
Reason: Per project curation policy, uninformative generic protein_binding is removed. Cyclin B1's informative molecular activity (CDK1 activation and substrate targeting) is captured by GO:0061575 / GO:0016538, and specific interactions such as protein kinase binding (GO:0019901) and patched binding (GO:0005113) are retained separately. Removal does not dispute the reported CDK1 interaction.
GO:0005515 protein binding
IPI
PMID:33961781
Dual proteome-scale networks reveal cell-specific remodeling...
REMOVE
Summary: Generic "protein binding" (interactor: CDKN1B (p27)). The interaction is not disputed, but GO:0005515 conveys no molecular function.
Reason: Per project curation policy, uninformative generic protein_binding is removed. Cyclin B1's informative molecular activity (CDK1 activation and substrate targeting) is captured by GO:0061575 / GO:0016538, and specific interactions such as protein kinase binding (GO:0019901) and patched binding (GO:0005113) are retained separately. Removal does not dispute the reported CDKN1B (p27) interaction.
GO:0005515 protein binding
IPI
PMID:33961781
Dual proteome-scale networks reveal cell-specific remodeling...
REMOVE
Summary: Generic "protein binding" (interactor: CDK5). The interaction is not disputed, but GO:0005515 conveys no molecular function.
Reason: Per project curation policy, uninformative generic protein_binding is removed. Cyclin B1's informative molecular activity (CDK1 activation and substrate targeting) is captured by GO:0061575 / GO:0016538, and specific interactions such as protein kinase binding (GO:0019901) and patched binding (GO:0005113) are retained separately. Removal does not dispute the reported CDK5 interaction.
GO:0005515 protein binding
IPI
PMID:33961781
Dual proteome-scale networks reveal cell-specific remodeling...
REMOVE
Summary: Generic "protein binding" (interactor: PKMYT1). The interaction is not disputed, but GO:0005515 conveys no molecular function.
Reason: Per project curation policy, uninformative generic protein_binding is removed. Cyclin B1's informative molecular activity (CDK1 activation and substrate targeting) is captured by GO:0061575 / GO:0016538, and specific interactions such as protein kinase binding (GO:0019901) and patched binding (GO:0005113) are retained separately. Removal does not dispute the reported PKMYT1 interaction.
GO:0005515 protein binding
IPI
PMID:34290405
Structural basis of human separase regulation by securin and...
REMOVE
Summary: Generic "protein binding" (interactor: CDK1). The interaction is not disputed, but GO:0005515 conveys no molecular function.
Reason: Per project curation policy, uninformative generic protein_binding is removed. Cyclin B1's informative molecular activity (CDK1 activation and substrate targeting) is captured by GO:0061575 / GO:0016538, and specific interactions such as protein kinase binding (GO:0019901) and patched binding (GO:0005113) are retained separately. Removal does not dispute the reported CDK1 interaction.
GO:0005515 protein binding
IPI
PMID:34591612
A protein interaction landscape of breast cancer.
REMOVE
Summary: Generic "protein binding" (interactor: CDKN1B (p27)). The interaction is not disputed, but GO:0005515 conveys no molecular function.
Reason: Per project curation policy, uninformative generic protein_binding is removed. Cyclin B1's informative molecular activity (CDK1 activation and substrate targeting) is captured by GO:0061575 / GO:0016538, and specific interactions such as protein kinase binding (GO:0019901) and patched binding (GO:0005113) are retained separately. Removal does not dispute the reported CDKN1B (p27) interaction.
GO:0005515 protein binding
IPI
PMID:35271311
OpenCell: Endogenous tagging for the cartography of human ce...
REMOVE
Summary: Generic "protein binding" (interactor: CDK1). The interaction is not disputed, but GO:0005515 conveys no molecular function.
Reason: Per project curation policy, uninformative generic protein_binding is removed. Cyclin B1's informative molecular activity (CDK1 activation and substrate targeting) is captured by GO:0061575 / GO:0016538, and specific interactions such as protein kinase binding (GO:0019901) and patched binding (GO:0005113) are retained separately. Removal does not dispute the reported CDK1 interaction.
GO:0005515 protein binding
IPI
PMID:35271311
OpenCell: Endogenous tagging for the cartography of human ce...
REMOVE
Summary: Generic "protein binding" (interactor: CDK5). The interaction is not disputed, but GO:0005515 conveys no molecular function.
Reason: Per project curation policy, uninformative generic protein_binding is removed. Cyclin B1's informative molecular activity (CDK1 activation and substrate targeting) is captured by GO:0061575 / GO:0016538, and specific interactions such as protein kinase binding (GO:0019901) and patched binding (GO:0005113) are retained separately. Removal does not dispute the reported CDK5 interaction.
GO:0005515 protein binding
IPI
PMID:35271311
OpenCell: Endogenous tagging for the cartography of human ce...
REMOVE
Summary: Generic "protein binding" (interactor: PKMYT1). The interaction is not disputed, but GO:0005515 conveys no molecular function.
Reason: Per project curation policy, uninformative generic protein_binding is removed. Cyclin B1's informative molecular activity (CDK1 activation and substrate targeting) is captured by GO:0061575 / GO:0016538, and specific interactions such as protein kinase binding (GO:0019901) and patched binding (GO:0005113) are retained separately. Removal does not dispute the reported PKMYT1 interaction.
GO:0005515 protein binding
IPI
PMID:8756624
Cyclin-binding motifs are essential for the function of p21C...
REMOVE
Summary: Generic "protein binding" (interactor: CDKN1B (p27)). The interaction is not disputed, but GO:0005515 conveys no molecular function.
Reason: Per project curation policy, uninformative generic protein_binding is removed. Cyclin B1's informative molecular activity (CDK1 activation and substrate targeting) is captured by GO:0061575 / GO:0016538, and specific interactions such as protein kinase binding (GO:0019901) and patched binding (GO:0005113) are retained separately. Removal does not dispute the reported CDKN1B (p27) interaction.
GO:0005515 protein binding
IPI
PMID:9001210
The human Myt1 kinase preferentially phosphorylates Cdc2 on ...
REMOVE
Summary: Generic "protein binding" (interactor: CDK1). The interaction is not disputed, but GO:0005515 conveys no molecular function.
Reason: Per project curation policy, uninformative generic protein_binding is removed. Cyclin B1's informative molecular activity (CDK1 activation and substrate targeting) is captured by GO:0061575 / GO:0016538, and specific interactions such as protein kinase binding (GO:0019901) and patched binding (GO:0005113) are retained separately. Removal does not dispute the reported CDK1 interaction.
Supporting Evidence:
PMID:9001210
Cdc2 associates with the B-type cyclins
GO:0005634 nucleus
IBA
GO_REF:0000033
ACCEPT
Summary: Cyclin B1 accumulates in the nucleus at prophase; nuclear localization is well established.
Reason: IBA localization consistent with UniProt (Nucleus) and multiple direct studies. CCNB1 itself is among the WITH/FROM sources, indicating experimental grounding on the target.
GO:0005634 nucleus
IDA
PMID:11331587
Patched1 interacts with cyclin B1 to regulate cell cycle pro...
ACCEPT
Summary: Nuclear localization of cyclin B1 (Barnes et al. 2001).
Reason: Direct immunolocalization; PTCH1/SHH regulate nuclear translocation of cyclin B1.
Supporting Evidence:
PMID:11331587
allows cyclin B1 to localize to the nucleus
GO:0005634 nucleus
IDA
PMID:16109376
The bromodomain protein Brd4 is a positive regulatory compon...
ACCEPT
Summary: Nuclear localization of cyclin B1.
Reason: Direct-assay nuclear localization annotation, consistent with the established prophase nuclear accumulation of cyclin B1.
GO:0005634 nucleus
IDA
PMID:20725088
Primate-specific RFPL1 gene controls cell-cycle progression ...
ACCEPT
Summary: Nuclear localization of cyclin B1 (RFPL1 study).
Reason: Direct-assay annotation consistent with cyclin B1 nuclear accumulation during the cell cycle.
GO:0005634 nucleus
IEA
GO_REF:0000120
ACCEPT
Summary: Nuclear localization by automated methods.
Reason: Consistent with experimental nucleus annotations above.
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-170044
ACCEPT
Summary: Nucleoplasm localization from Reactome mitotic pathways.
Reason: TAS localization consistent with the nuclear pool of cyclin B1-CDK1 acting on nuclear mitotic substrates. Multiple duplicate Reactome sources; all consistent.
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-170070
ACCEPT
Summary: Nucleoplasm localization from Reactome mitotic pathways.
Reason: TAS localization consistent with the nuclear pool of cyclin B1-CDK1 acting on nuclear mitotic substrates. Multiple duplicate Reactome sources; all consistent.
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-170072
ACCEPT
Summary: Nucleoplasm localization from Reactome mitotic pathways.
Reason: TAS localization consistent with the nuclear pool of cyclin B1-CDK1 acting on nuclear mitotic substrates. Multiple duplicate Reactome sources; all consistent.
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-170076
ACCEPT
Summary: Nucleoplasm localization from Reactome mitotic pathways.
Reason: TAS localization consistent with the nuclear pool of cyclin B1-CDK1 acting on nuclear mitotic substrates. Multiple duplicate Reactome sources; all consistent.
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-170131
ACCEPT
Summary: Nucleoplasm localization from Reactome mitotic pathways.
Reason: TAS localization consistent with the nuclear pool of cyclin B1-CDK1 acting on nuclear mitotic substrates. Multiple duplicate Reactome sources; all consistent.
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-170153
ACCEPT
Summary: Nucleoplasm localization from Reactome mitotic pathways.
Reason: TAS localization consistent with the nuclear pool of cyclin B1-CDK1 acting on nuclear mitotic substrates. Multiple duplicate Reactome sources; all consistent.
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-174122
ACCEPT
Summary: Nucleoplasm localization from Reactome mitotic pathways.
Reason: TAS localization consistent with the nuclear pool of cyclin B1-CDK1 acting on nuclear mitotic substrates. Multiple duplicate Reactome sources; all consistent.
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-174132
ACCEPT
Summary: Nucleoplasm localization from Reactome mitotic pathways.
Reason: TAS localization consistent with the nuclear pool of cyclin B1-CDK1 acting on nuclear mitotic substrates. Multiple duplicate Reactome sources; all consistent.
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-174251
ACCEPT
Summary: Nucleoplasm localization from Reactome mitotic pathways.
Reason: TAS localization consistent with the nuclear pool of cyclin B1-CDK1 acting on nuclear mitotic substrates. Multiple duplicate Reactome sources; all consistent.
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-2245218
ACCEPT
Summary: Nucleoplasm localization from Reactome mitotic pathways.
Reason: TAS localization consistent with the nuclear pool of cyclin B1-CDK1 acting on nuclear mitotic substrates. Multiple duplicate Reactome sources; all consistent.
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-2294600
ACCEPT
Summary: Nucleoplasm localization from Reactome mitotic pathways.
Reason: TAS localization consistent with the nuclear pool of cyclin B1-CDK1 acting on nuclear mitotic substrates. Multiple duplicate Reactome sources; all consistent.
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-380278
ACCEPT
Summary: Nucleoplasm localization from Reactome mitotic pathways.
Reason: TAS localization consistent with the nuclear pool of cyclin B1-CDK1 acting on nuclear mitotic substrates. Multiple duplicate Reactome sources; all consistent.
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-4088024
ACCEPT
Summary: Nucleoplasm localization from Reactome mitotic pathways.
Reason: TAS localization consistent with the nuclear pool of cyclin B1-CDK1 acting on nuclear mitotic substrates. Multiple duplicate Reactome sources; all consistent.
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-4088298
ACCEPT
Summary: Nucleoplasm localization from Reactome mitotic pathways.
Reason: TAS localization consistent with the nuclear pool of cyclin B1-CDK1 acting on nuclear mitotic substrates. Multiple duplicate Reactome sources; all consistent.
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-5195402
ACCEPT
Summary: Nucleoplasm localization from Reactome mitotic pathways.
Reason: TAS localization consistent with the nuclear pool of cyclin B1-CDK1 acting on nuclear mitotic substrates. Multiple duplicate Reactome sources; all consistent.
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-5244669
ACCEPT
Summary: Nucleoplasm localization from Reactome mitotic pathways.
Reason: TAS localization consistent with the nuclear pool of cyclin B1-CDK1 acting on nuclear mitotic substrates. Multiple duplicate Reactome sources; all consistent.
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-9009282
ACCEPT
Summary: Nucleoplasm localization from Reactome mitotic pathways.
Reason: TAS localization consistent with the nuclear pool of cyclin B1-CDK1 acting on nuclear mitotic substrates. Multiple duplicate Reactome sources; all consistent.
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-9851092
ACCEPT
Summary: Nucleoplasm localization from Reactome mitotic pathways.
Reason: TAS localization consistent with the nuclear pool of cyclin B1-CDK1 acting on nuclear mitotic substrates. Multiple duplicate Reactome sources; all consistent.
GO:0005654 nucleoplasm
TAS
Reactome:R-NUL-2434198
ACCEPT
Summary: Nucleoplasm localization from Reactome mitotic pathways.
Reason: TAS localization consistent with the nuclear pool of cyclin B1-CDK1 acting on nuclear mitotic substrates. Multiple duplicate Reactome sources; all consistent.
GO:0005737 cytoplasm
IBA
GO_REF:0000033
ACCEPT
Summary: Cyclin B1 is predominantly cytoplasmic during interphase; is_active_in cytoplasm.
Reason: IBA localization; cyclin B1-CDK1 is first activated in the cytoplasm/centrosome. CCNB1 appears among its own WITH/FROM sources (experimental grounding on target).
GO:0005737 cytoplasm
IDA
PMID:11331587
Patched1 interacts with cyclin B1 to regulate cell cycle pro...
ACCEPT
Summary: Cytoplasmic localization of cyclin B1 (Barnes et al. 2001).
Reason: Direct localization; PTCH1 sequesters phospho-cyclin B1 in the cytoplasm.
GO:0005737 cytoplasm
IDA
PMID:17850284
Immunohistochemical analysis of Sonic hedgehog signalling in...
ACCEPT
Summary: Cytoplasmic cyclin B1 by immunohistochemistry in developing human urinary tract.
Reason: Direct immunohistochemical localization consistent with the cytoplasmic interphase pool of cyclin B1.
Supporting Evidence:
PMID:17850284
regulating the subcellular localisation of Cyclin B1
GO:0005737 cytoplasm
IDA
PMID:20725088
Primate-specific RFPL1 gene controls cell-cycle progression ...
ACCEPT
Summary: Cytoplasmic localization of cyclin B1 (RFPL1 study).
Reason: Direct-assay annotation; cytoplasm-localized RFPL1 prevents cyclin B1 accumulation during interphase.
Supporting Evidence:
PMID:20725088
cytoplasm-localized hRFPL1 prevented cyclin B1 and Cdc2 accumulation during interphase
GO:0005737 cytoplasm
IEA
GO_REF:0000120
ACCEPT
Summary: Cytoplasm localization by automated methods.
Reason: Consistent with experimental cytoplasm annotations.
GO:0005759 mitochondrial matrix
IBA
GO_REF:0000033
KEEP AS NON CORE
Summary: A fraction of cyclin B1-CDK1 colocalizes with the mitochondrial matrix (Wang et al. 2014).
Reason: Genuine but non-core moonlighting localization supporting mitochondrial respiration; the IBA node carries CCNB1 in its own WITH/FROM, reflecting the direct human evidence. Retained as non-core.
GO:0005759 mitochondrial matrix
IDA
PMID:24746669
Cyclin B1/Cdk1 coordinates mitochondrial respiration for cel...
KEEP AS NON CORE
Summary: A fraction of cyclin B1-CDK1 directly localizes to the mitochondrial matrix (Wang et al. 2014).
Reason: Directly demonstrated moonlighting localization supporting mitochondrial respiration during G2/M; genuine but peripheral to the core mitotic CDK-activation function, so kept as non-core (consistent with the IBA/IEA mitochondrial-matrix annotations).
Supporting Evidence:
PMID:24746669
a fraction of cyclin B1/Cdk1 proteins localizes to the matrix of mitochondria and phosphorylates a cluster of mitochondrial proteins
GO:0005759 mitochondrial matrix
IEA
GO_REF:0000107
KEEP AS NON CORE
Summary: Mitochondrial matrix colocalization by automated ortholog transfer.
Reason: Non-core moonlighting localization consistent with the direct evidence (PMID:24746669).
GO:0005813 centrosome
IDA
PMID:12524548
Active cyclin B1-Cdk1 first appears on centrosomes in propha...
ACCEPT
Summary: Active cyclin B1-CDK1 first appears on centrosomes in prophase (Jackman et al. 2003).
Reason: Direct evidence that the active complex is first detected at centrosomes, an important site of mitotic initiation.
Supporting Evidence:
PMID:12524548
cyclin B1 is initially phosphorylated on centrosomes in prophase
GO:0005813 centrosome
IEA
GO_REF:0000044
ACCEPT
Summary: Centrosome localization by automated subcellular-location mapping.
Reason: Consistent with the direct centrosome annotation (PMID:12524548).
GO:0005815 microtubule organizing center
IBA
GO_REF:0000033
ACCEPT
Summary: Microtubule organizing center (centrosome) localization; is_active_in.
Reason: MTOC/centrosome is where active cyclin B1-CDK1 first appears; consistent across species (IBA).
GO:0005829 cytosol
IDA
GO_REF:0000052
ACCEPT
Summary: Cytosolic localization from immunofluorescence curation.
Reason: Consistent with the cytoplasmic interphase pool of cyclin B1.
GO:0005829 cytosol
IEA
GO_REF:0000117
ACCEPT
Summary: Cytosol localization by ARBA machine-learning model.
Reason: Consistent with experimental cytoplasm/cytosol localization.
GO:0005829 cytosol
TAS
Reactome:R-HSA-170044
ACCEPT
Summary: Cytosol localization from Reactome mitotic pathways.
Reason: TAS localization consistent with the cytoplasmic pool of cyclin B1-CDK1. Multiple duplicate Reactome sources; all consistent.
GO:0005829 cytosol
TAS
Reactome:R-HSA-170055
ACCEPT
Summary: Cytosol localization from Reactome mitotic pathways.
Reason: TAS localization consistent with the cytoplasmic pool of cyclin B1-CDK1. Multiple duplicate Reactome sources; all consistent.
GO:0005829 cytosol
TAS
Reactome:R-HSA-170057
ACCEPT
Summary: Cytosol localization from Reactome mitotic pathways.
Reason: TAS localization consistent with the cytoplasmic pool of cyclin B1-CDK1. Multiple duplicate Reactome sources; all consistent.
GO:0005829 cytosol
TAS
Reactome:R-HSA-170072
ACCEPT
Summary: Cytosol localization from Reactome mitotic pathways.
Reason: TAS localization consistent with the cytoplasmic pool of cyclin B1-CDK1. Multiple duplicate Reactome sources; all consistent.
GO:0005829 cytosol
TAS
Reactome:R-HSA-170126
ACCEPT
Summary: Cytosol localization from Reactome mitotic pathways.
Reason: TAS localization consistent with the cytoplasmic pool of cyclin B1-CDK1. Multiple duplicate Reactome sources; all consistent.
GO:0005829 cytosol
TAS
Reactome:R-HSA-170131
ACCEPT
Summary: Cytosol localization from Reactome mitotic pathways.
Reason: TAS localization consistent with the cytoplasmic pool of cyclin B1-CDK1. Multiple duplicate Reactome sources; all consistent.
GO:0005829 cytosol
TAS
Reactome:R-HSA-170161
ACCEPT
Summary: Cytosol localization from Reactome mitotic pathways.
Reason: TAS localization consistent with the cytoplasmic pool of cyclin B1-CDK1. Multiple duplicate Reactome sources; all consistent.
GO:0005829 cytosol
TAS
Reactome:R-HSA-174120
ACCEPT
Summary: Cytosol localization from Reactome mitotic pathways.
Reason: TAS localization consistent with the cytoplasmic pool of cyclin B1-CDK1. Multiple duplicate Reactome sources; all consistent.
GO:0005829 cytosol
TAS
Reactome:R-HSA-174157
ACCEPT
Summary: Cytosol localization from Reactome mitotic pathways.
Reason: TAS localization consistent with the cytoplasmic pool of cyclin B1-CDK1. Multiple duplicate Reactome sources; all consistent.
GO:0005829 cytosol
TAS
Reactome:R-HSA-174227
ACCEPT
Summary: Cytosol localization from Reactome mitotic pathways.
Reason: TAS localization consistent with the cytoplasmic pool of cyclin B1-CDK1. Multiple duplicate Reactome sources; all consistent.
GO:0005829 cytosol
TAS
Reactome:R-HSA-2468287
ACCEPT
Summary: Cytosol localization from Reactome mitotic pathways.
Reason: TAS localization consistent with the cytoplasmic pool of cyclin B1-CDK1. Multiple duplicate Reactome sources; all consistent.
GO:0005829 cytosol
TAS
Reactome:R-HSA-2468293
ACCEPT
Summary: Cytosol localization from Reactome mitotic pathways.
Reason: TAS localization consistent with the cytoplasmic pool of cyclin B1-CDK1. Multiple duplicate Reactome sources; all consistent.
GO:0005829 cytosol
TAS
Reactome:R-HSA-2984220
ACCEPT
Summary: Cytosol localization from Reactome mitotic pathways.
Reason: TAS localization consistent with the cytoplasmic pool of cyclin B1-CDK1. Multiple duplicate Reactome sources; all consistent.
GO:0005829 cytosol
TAS
Reactome:R-HSA-2990882
ACCEPT
Summary: Cytosol localization from Reactome mitotic pathways.
Reason: TAS localization consistent with the cytoplasmic pool of cyclin B1-CDK1. Multiple duplicate Reactome sources; all consistent.
GO:0005829 cytosol
TAS
Reactome:R-HSA-4086410
ACCEPT
Summary: Cytosol localization from Reactome mitotic pathways.
Reason: TAS localization consistent with the cytoplasmic pool of cyclin B1-CDK1. Multiple duplicate Reactome sources; all consistent.
GO:0005829 cytosol
TAS
Reactome:R-HSA-6803875
ACCEPT
Summary: Cytosol localization from Reactome mitotic pathways.
Reason: TAS localization consistent with the cytoplasmic pool of cyclin B1-CDK1. Multiple duplicate Reactome sources; all consistent.
GO:0005829 cytosol
TAS
Reactome:R-HSA-9624800
ACCEPT
Summary: Cytosol localization from Reactome mitotic pathways.
Reason: TAS localization consistent with the cytoplasmic pool of cyclin B1-CDK1. Multiple duplicate Reactome sources; all consistent.
GO:0005829 cytosol
TAS
Reactome:R-HSA-9858641
ACCEPT
Summary: Cytosol localization from Reactome mitotic pathways.
Reason: TAS localization consistent with the cytoplasmic pool of cyclin B1-CDK1. Multiple duplicate Reactome sources; all consistent.
GO:0005829 cytosol
TAS
Reactome:R-NUL-2422970
ACCEPT
Summary: Cytosol localization from Reactome mitotic pathways.
Reason: TAS localization consistent with the cytoplasmic pool of cyclin B1-CDK1. Multiple duplicate Reactome sources; all consistent.
GO:0007052 mitotic spindle organization
IMP
PMID:18195732
Cyclin B1 is localized to unattached kinetochores and contri...
ACCEPT
Summary: Cyclin B1 depletion impairs spindle-microtubule/kinetochore function and mitotic progression (Chen et al. 2008).
Reason: Experimental IMP (siRNA) from a paper whose full text the curator read; kinetochore-localized cyclin B1-CDK1 contributes to correct spindle-microtubule attachment. A downstream mitotic role executed via CDK1 substrate phosphorylation.
Supporting Evidence:
PMID:18195732
inefficient attachment between kinetochores and microtubules
GO:0007080 mitotic metaphase chromosome alignment
IBA
GO_REF:0000033
ACCEPT
Summary: Mitotic metaphase chromosome alignment; IBA and IMP both support a role.
Reason: Phylogenetically inferred and experimentally supported (Chen et al. 2008 siRNA causes chromosome alignment defects). CCNB1 is in the IBA WITH/FROM, reflecting target experimental grounding.
GO:0007080 mitotic metaphase chromosome alignment
IMP
PMID:18195732
Cyclin B1 is localized to unattached kinetochores and contri...
ACCEPT
Summary: Cyclin B1 depletion causes chromosome alignment defects (Chen et al. 2008).
Reason: Experimental IMP: kinetochore cyclin B1-CDK1 promotes efficient chromosome alignment.
Supporting Evidence:
PMID:18195732
chromosome alignment defects
GO:0007283 spermatogenesis
IEA
GO_REF:0000107
KEEP AS NON CORE
Summary: Cyclin B1 has conserved roles in male meiosis; electronically transferred from the rat ortholog.
Reason: A genuine but developmental/context-specific role (meiotic MPF) supported only by automated ortholog transfer; retained as non-core.
GO:0009410 response to xenobiotic stimulus
IEA
GO_REF:0000107
MARK AS OVER ANNOTATED
Summary: Response-to-xenobiotic transferred from the rat ortholog; reflects abundance/expression change, not participation.
Reason: Cyclin B1 levels change in response to many stimuli, but the protein does not execute a step of a xenobiotic-response process; automated ortholog transfer over-annotates a downstream expression readout.
GO:0009612 response to mechanical stimulus
IEA
GO_REF:0000107
MARK AS OVER ANNOTATED
Summary: Response-to-mechanical-stimulus (rat ortholog IEA); expression response, not participation.
Reason: As for other rat-ortholog response terms: reflects a change in cyclin B1 level, not participation of the protein in the process.
GO:0009636 response to toxic substance
IEA
GO_REF:0000107
MARK AS OVER ANNOTATED
Summary: Response-to-toxic-substance (rat ortholog IEA); expression response, not participation.
Reason: Downstream abundance readout transferred electronically; cyclin B1 does not perform a step of this process.
GO:0010629 negative regulation of gene expression
IEA
GO_REF:0000107
MARK AS OVER ANNOTATED
Summary: Negative regulation of gene expression (rat ortholog IEA); indirect/over-broad.
Reason: Cyclin B1 does not directly regulate gene expression; any effect is an indirect consequence of cell-cycle progression. Over-annotation from automated ortholog transfer.
GO:0010971 positive regulation of G2/M transition of mitotic cell cycle
IDA
PMID:24746669
Cyclin B1/Cdk1 coordinates mitochondrial respiration for cel...
ACCEPT
Summary: Cyclin B1-CDK1 positively regulates the G2/M transition (Wang et al. 2014).
Reason: Direct evidence that mitochondrial cyclin B1-CDK1 activity provides bioenergy that promotes G2/M transition; consistent with the core mitotic-entry role.
Supporting Evidence:
PMID:24746669
efficient bioenergy for G2/M transition
GO:0016020 membrane
IEA
GO_REF:0000107
REMOVE
Summary: Membrane localization transferred from the rat ortholog; cyclin B1 is not a membrane protein.
Reason: Cyclin B1 has no transmembrane or signal-anchor features and is a soluble cytoplasmic/nuclear/centrosomal protein. This is a spurious automated localization transfer and is demonstrably wrong.
GO:0016538 cyclin-dependent protein serine/threonine kinase regulator activity
IBA
GO_REF:0000033
ACCEPT
Summary: Core molecular function: cyclin-dependent protein serine/threonine kinase regulator activity.
Reason: The defining activity of a cyclin: it modulates (activates and directs) CDK1. IBA at the correct level; CCNB1 is among the WITH/FROM sources.
Supporting Evidence:
PMID:17495531
The cyclins activate their respective CDKs and confer substrate recognition properties
GO:0016538 cyclin-dependent protein serine/threonine kinase regulator activity
IEA
GO_REF:0000002
ACCEPT
Summary: CDK regulator activity from InterPro cyclin domain mapping.
Reason: Consistent with the core cyclin function; domain-based IEA is appropriate.
GO:0019901 protein kinase binding
IEA
GO_REF:0000107
ACCEPT
Summary: Protein kinase (CDK1) binding; automated transfer.
Reason: A specific, informative binding term underlying the cyclin-CDK1 interaction; consistent with experimental IPI evidence.
GO:0019901 protein kinase binding
IPI
PMID:12524548
Active cyclin B1-Cdk1 first appears on centrosomes in propha...
ACCEPT
Summary: Cyclin B1 binds the protein kinase PLK1 (Jackman et al. 2003).
Reason: PLK1 phosphorylates cyclin B1 on centrosomes in prophase; protein kinase binding is a specific, informative term (retained rather than removed as generic binding).
Supporting Evidence:
PMID:12524548
Plk1 phosphorylates cyclin B1
GO:0019901 protein kinase binding
IPI
PMID:24746669
Cyclin B1/Cdk1 coordinates mitochondrial respiration for cel...
ACCEPT
Summary: Cyclin B1 binds the protein kinase CDK1 (Wang et al. 2014).
Reason: The core CDK1 partnership expressed as a specific protein kinase binding annotation; retained.
Supporting Evidence:
PMID:24746669
cyclin B1/Cdk1
GO:0031442 positive regulation of mRNA 3'-end processing
IEA
GO_REF:0000107
MARK AS OVER ANNOTATED
Summary: Positive regulation of mRNA 3'-end processing (rat ortholog IEA); indirect.
Reason: No direct evidence cyclin B1 participates in mRNA 3'-end processing in human; an indirect/over-propagated ortholog transfer.
GO:0042246 tissue regeneration
IEA
GO_REF:0000107
MARK AS OVER ANNOTATED
Summary: Tissue regeneration (rat ortholog IEA); pleiotropic proliferation effect.
Reason: Reflects the general requirement for proliferation, not a specific participation of cyclin B1 in a regeneration process. Over-annotation.
GO:0044389 ubiquitin-like protein ligase binding
IPI
PMID:15749827
A novel UbcH10-binding protein facilitates the ubiquitinylat...
KEEP AS NON CORE
Summary: Cyclin B1 is bound and ubiquitinated in vitro by an UbcH10-binding E3 (H10BH/UBE3D).
Reason: A specific binding term (binding an E3 ligase) reflecting cyclin B1's role as a ubiquitination substrate. In vitro evidence for an obscure E3; peripheral to core function, retained as non-core.
Supporting Evidence:
PMID:15749827
bind cyclin B and ubiquitinylate cyclin B in vitro
GO:0044772 mitotic cell cycle phase transition
IEA
GO_REF:0000002
ACCEPT
Summary: Mitotic cell cycle phase transition (InterPro IEA); broad but correct.
Reason: Correct broad process for a mitotic cyclin; consistent with the G2/M and mitotic annotations.
GO:0045931 positive regulation of mitotic cell cycle
IMP
PMID:18195732
Cyclin B1 is localized to unattached kinetochores and contri...
ACCEPT
Summary: Cyclin B1 positively regulates mitotic cell cycle progression (Chen et al. 2008).
Reason: Experimental IMP: cyclin B1 depletion delays anaphase onset and slows mitotic progression.
Supporting Evidence:
PMID:18195732
delays the onset of anaphase
GO:0046680 response to DDT
IEA
GO_REF:0000107
MARK AS OVER ANNOTATED
Summary: Response to DDT (rat ortholog IEA); expression response, not participation.
Reason: Downstream abundance readout transferred electronically; not participation of cyclin B1 in the process.
GO:0048565 digestive tract development
IEA
GO_REF:0000107
MARK AS OVER ANNOTATED
Summary: Digestive tract development (rat ortholog IEA); pleiotropic proliferation effect.
Reason: Reflects general proliferation during development, not a specific cyclin B1 role in gut morphogenesis. Over-annotation.
GO:0051987 positive regulation of attachment of spindle microtubules to kinetochore
IMP
PMID:18195732
Cyclin B1 is localized to unattached kinetochores and contri...
ACCEPT
Summary: Cyclin B1 promotes efficient spindle-microtubule attachment to kinetochores (Chen et al. 2008).
Reason: Experimental IMP; kinetochore-localized cyclin B1-CDK1 contributes to correct microtubule attachment.
Supporting Evidence:
PMID:18195732
contributes to the correct attachment of microtubules to kinetochores
GO:0055015 ventricular cardiac muscle cell development
IEA
GO_REF:0000107
MARK AS OVER ANNOTATED
Summary: Ventricular cardiac muscle cell development (rat ortholog IEA); pleiotropic.
Reason: Reflects general proliferation, not a specific cyclin B1 participation. Over-annotation from ortholog transfer.
GO:0060045 positive regulation of cardiac muscle cell proliferation
IEA
GO_REF:0000107
MARK AS OVER ANNOTATED
Summary: Positive regulation of cardiac muscle cell proliferation (rat ortholog IEA); pleiotropic.
Reason: A generic consequence of driving the cell cycle in a particular tissue rather than a distinct cyclin B1 function; over-annotation.
GO:0060623 regulation of chromosome condensation
IEA
GO_REF:0000107
KEEP AS NON CORE
Summary: Cyclin B1-CDK1 phosphorylates condensin subunits, contributing to mitotic chromosome condensation.
Reason: A genuine downstream mitotic role (e.g. condensin II NCAPD3 phosphorylation) but electronically transferred here and peripheral to the core CDK-activation function; retained as non-core.
GO:0061575 cyclin-dependent protein serine/threonine kinase activator activity
IDA
PMID:24746669
Cyclin B1/Cdk1 coordinates mitochondrial respiration for cel...
ACCEPT
Summary: Core molecular function: cyclin-dependent protein serine/threonine kinase ACTIVATOR activity (binds and activates CDK1).
Reason: The most specific correct MF for cyclin B1 and the term used in the CCNB1 GO-CAM. Direct evidence that cyclin B1 binds and activates CDK1.
Supporting Evidence:
PMID:24746669
cyclin B1/Cdk1
GO:0065003 protein-containing complex assembly
IEA
GO_REF:0000107
MARK AS OVER ANNOTATED
Summary: Protein-containing complex assembly (rat ortholog IEA); over-broad.
Reason: While cyclin B1 forms the cyclin B1-CDK1 complex, this generic term (any complex assembly) is an over-broad electronic transfer; complex membership is captured by GO:0097125.
GO:0071283 cellular response to iron(III) ion
IEA
GO_REF:0000107
MARK AS OVER ANNOTATED
Summary: Cellular response to iron(III) ion (rat ortholog IEA); expression response.
Reason: Abundance/expression readout, not participation; over-annotation from automated ortholog transfer.
GO:0071398 cellular response to fatty acid
IEA
GO_REF:0000107
MARK AS OVER ANNOTATED
Summary: Cellular response to fatty acid (rat ortholog IEA); expression response.
Reason: Abundance/expression readout, not participation; over-annotation.
GO:0071456 cellular response to hypoxia
IEA
GO_REF:0000107
MARK AS OVER ANNOTATED
Summary: Cellular response to hypoxia (rat ortholog IEA); expression response.
Reason: Cyclin B1 abundance changes with hypoxia-linked cell-cycle arrest, but the protein does not execute a hypoxia-response step; over-annotation.
GO:0090266 regulation of mitotic cell cycle spindle assembly checkpoint
IMP
PMID:18195732
Cyclin B1 is localized to unattached kinetochores and contri...
ACCEPT
Summary: Cyclin B1-CDK1 regulates the spindle assembly checkpoint (Chen et al. 2008; Hayward et al. 2019).
Reason: Experimental IMP: relocalization of cyclin B1 from kinetochores upon attachment contributes to SAC silencing, and cyclin B1-CDK1 creates a checkpoint-permissive state by enabling MPS1 kinetochore localization.
Supporting Evidence:
PMID:18195732
contribute to inactivation of the spindle assembly checkpoint
GO:0097125 cyclin B1-CDK1 complex
IBA
GO_REF:0000033
ACCEPT
Summary: Cyclin B1-CDK1 complex membership; is part_of. IBA at the correct level.
Reason: Core complex; CCNB1 is among its own WITH/FROM sources (experimental grounding on the target).
GO:0097125 cyclin B1-CDK1 complex
IDA
PMID:24746669
Cyclin B1/Cdk1 coordinates mitochondrial respiration for cel...
ACCEPT
Summary: Direct evidence of the cyclin B1-CDK1 complex (Wang et al. 2014).
Reason: The cyclin B1-CDK1 holoenzyme (MPF) is directly assayed.
Supporting Evidence:
PMID:24746669
cyclin B1/Cdk1
GO:0097125 cyclin B1-CDK1 complex
IPI
PMID:17495531
Cyclin B and cyclin A confer different substrate recognition...
ACCEPT
Summary: Structural characterization of the cyclin B-CDK complex (Brown et al. 2007).
Reason: Crystal structure of phospho-CDK2/cyclin B directly demonstrates the complex and the substrate-recognition role of the cyclin.
Supporting Evidence:
PMID:17495531
We report the structure of phospho-CDK2/cyclin B
GO:1905448 positive regulation of mitochondrial ATP synthesis coupled electron transport
IDA
PMID:24746669
Cyclin B1/Cdk1 coordinates mitochondrial respiration for cel...
KEEP AS NON CORE
Summary: Mitochondrial cyclin B1-CDK1 phosphorylates complex I subunits and enhances respiration (Wang et al. 2014).
Reason: A genuine, directly demonstrated moonlighting function that supports G2/M energetics, but distinct from and peripheral to the core mitotic CDK-activation role; retained as non-core.
Supporting Evidence:
PMID:24746669
Cyclin B1/Cdk1-mediated CI phosphorylation enhances CI activity

Core Functions

Binds and activates the CDK1 (CDC2) serine/threonine protein kinase to form the cyclin B1-CDK1 holoenzyme (M-phase promoting factor, MPF); rising complex activity drives the G2/M transition and mitotic entry.

Supporting Evidence:
  • PMID:12524548
    Cyclin B1-Cdk1 is the key initiator of mitosis
  • PMID:24746669
    cyclin B1/Cdk1
  • file:human/CCNB1/CCNB1-deep-research-falcon.md
    Cyclin B1 is not itself an enzyme. Its primary function is to bind and activate the catalytic serine/threonine kinase CDK1, forming the cyclin-B1-CDK1 complex, historically termed maturation- or M-phase-promoting factor.

As the regulatory subunit of CDK1, confers substrate specificity and dynamic subcellular targeting on the kinase, directing localized phosphorylation of mitotic substrates at centrosomes, spindle, chromosomes and kinetochores to drive mitotic nuclear division, metaphase chromosome alignment and spindle-assembly-checkpoint control.

Supporting Evidence:
  • PMID:17495531
    The cyclins activate their respective CDKs and confer substrate recognition properties
  • PMID:18195732
    cyclin B1 accumulates at kinetochores during prometaphase, where it contributes to the correct attachment of microtubules to kinetochores and efficient alignment of the chromosomes

References

Loading supporting content…

Download this section (compressed HTML)

Suggested Questions for Experts

Q: Which mitotic substrates strictly require kinetochore- or centrosome-localized cyclin B1-CDK1 (versus the nuclear or cytoplasmic pool), and how does this spatial partitioning order the events of mitosis?

Q: To what extent is the mitochondrial-matrix cyclin B1-CDK1 pool that phosphorylates complex I a physiologically dedicated function versus a low-level consequence of high mitotic CDK1 activity?

Suggested Experiments

Experiment: Combine analog-sensitive CDK1 with rapid, degron-controlled removal of cyclin B1 and quantitative phosphoproteomics across synchronized mitosis to map the cyclin B1-dependent CDK1 substrate set and separate direct targets from indirect effects.

Experiment: Use endogenously tagged cyclin B1 with live super-resolution imaging plus localization-signal mutants (chromatin arginine anchor, NES/CRS, hydrophobic patch) to dissect how each subcellular pool contributes to distinct mitotic events and to APC/C-mediated destruction timing.

Deep Research

Falcon

(CCNB1-deep-research-falcon.md)

Loading supporting content…

Download this section (compressed HTML)

πŸ“š Additional Documentation

Notes

(CCNB1-notes.md)

Loading supporting content…

Download this section (compressed HTML)

πŸ“„ View Raw YAML

Loading supporting content…

Download this section (compressed HTML)